Coronavirus vaccine education will be key to distribution success, doctor says
November 11 2020, 08:00
News that pharmaceutical giant Pfizer and BioNTech's coronavirus vaccine candidate showed 90% efficacy in phase 3 clinical trial was applauded by infectious disease experts on Monday — but getting both the medical community and the public to receive the vaccine, should it be authorized by the U.S. Food and Drug Administration (FDA) will rely heavily on vaccine education, one doctor told Fox News.
News that pharmaceutical giant Pfizer and BioNTech's coronavirus vaccine candidate showed 90% efficacy in phase 3 clinical trial was applauded by infectious disease experts on Monday — but getting both the medical community and the public to receive the vaccine, should it be authorized by the U.S. Food and Drug Administration (FDA) will rely heavily on vaccine education, one doctor told Fox News.
Source:
FOX News